Global innovation in healthcare takes teamwork. That’s why we partner with the most forward-thinking biopharma, medtech and technology companies, as well as provider organizations. The BrightInsight Ecosystem of partners is solving the biggest healthcare challenges to drive digital engagement and put the patient at the center.
BrightInsight partnered with bioMérieux, a world leader in the field of in vitro diagnostics, to develop and bring to market a Clinical Digital Solution for diagnostics that will enable clinical decision support for disease areas across diagnostic testing.Learn More
The Claritas Rx platform illuminates the patient experience for specialty biopharma products, providing actionable insights into access, duration of therapy, and other metrics. With these insights, biopharma customers can deploy digital solutions with BrightInsight to address pain points along the patient journey.
Cooley is the #1 law firm for tech and life sciences IPOs, and partners with BrightInsight on legal and regulatory support.
BrightInsight and CSL Behring have a global digital health partnership to improve treatment experience for patients with rare diseases.Learn More
Eclipse Ventures, a leading technology investment firm that helps entrepreneurs build companies that will boldly transform the industries that define and propel economies, is an investor in BrightInsight.
Flex, a global leader in design and manufacturing, is a strategic partner and investor in BrightInsight.
FPT Software is a global leading technology and IT services, headquartered in Vietnam, specializing in Software Development, Embedded Systems, Digital Platforms, Data, RPA, AI, IoT, Cloud, Interoperability, and more.
General Catalyst, the world-renowned venture capital firm, is an investor in BrightInsight.
With decades of experience in regulated software product development and engineering services, GlobalLogic helps the world’s leading medical technology, medical devices, pharma, and life sciences organizations create world-class digital patient experiences, accelerate new product development, and capture new revenue streams.
Guidea is an award winning UX agency providing research and design for medtech, femtech, IoT, SaMD, and population health insights. Guidea has partnered with BrightInsight since 2018 on research driven product innovation, design innovation and formative and summative studies for HFE packaging.
Guidepoint is a market research partner of BrightInsight's for biopharma market landscaping and targeted therapeutic category insights.
HealthXL is a global digital health community of senior leaders of which Brightinsight are members.
Insight Partners, the premier global investor in scaling enterprise software companies, is an investor in BrightInsight.
ixlayer is redefining next generation patient experiences for lab testing and better health outcomes. They make it easy for people to test outside of clinical settings and take proactive steps towards better health. ixlayer’s platform enables patient-friendly digital experiences, thousands of testing options and seamless integration with customers and lab partners.
New Leaf Ventures, a venture capital firm funding the healthcare revolution by investing exclusively in companies revolutionizing healthcare, is an investor in BrightInsight.
Novo Nordisk and BrightInsight are partnered to develop digital health solutions for diabetes patients.
Rare Patient Voice is a critical partner in BrightInsight's mission to improve patient outcomes, specifically in helping recruit patients with rare clinical conditions to ensure we understand their persistent unmet needs while developing innovative digital solutions.
Rhapsody partners with healthcare organizations around the globe delivering its Interoperability Suite to reliably connect, classify, and clean data. Rhapsody health solutions connect more than 1 million data endpoints across more than 1,700 healthcare organizations and over 3,000 applications. Rhapsody powers accurate and flexible data integration for the BrightInsight Platform.Learn More
Schlesinger Group is BrightInsight's primary recruitment partner for digital health end-users, supporting us in our mission of improving patient outcomes.
Shapiro + Raj is a market research partner of BrightInsight's to support our Voice of Customer program with professional and B2B focused insights.
Slalom is a purpose-led, global business and technology consulting company. Our purpose is to help people and organizations dream bigger, move faster, and build better tomorrows for all.
Woebot Health is the world’s first mental health ally for people and businesses, with products that put personal growth in people’s hands, wherever they are.
Xealth and BrightInsight are partnering to explore ways for patients to benefit from a more coordinated approach between health systems and life sciences, from doctors and care teams who prescribe therapeutics, to life science companies creating innovative therapies and associated digital tools.
in capital raised
from top tier investors
Software as a Medical Device disease management solution for one of Sanofi’s most important treatments
Fill out our form and someone will be in touch!